Intestinal ischemic manifestations of SARS-CoV-2: Results from the ABDOCOVID multicentre study

Table 1 Patients clinical characteristics upon admission

Patients	Age	Sex	Comorbidities	Ongoing ACT/APT	Entry symptoms	D-dimer
1	85	M	HT, CVD	Yes	Low GI bleeding	Not done
2	71	F	HT	Yes	Loss of appetite, vomiting, low GI bleeding	10 N
3	69	M	DM, liver cirrhosis	No	Diarrhoea, fever and dyspnea	8 N
4	79	F	HT, CVD, HCV	Yes	Abdominal pain	8 N
5	63	M	No	No	Lower limb pain	> 70 N
6	62	M	Obesity, DM, HT, liver cirrhosis	No	Abdominal pain and vomiting	> 70 N
7	83	F	HT	Yes	Abdominal pain and dyspnoea	4 N
8	65	M	No	No	Abdominal pain	Not done
9	88	M	CVD	Yes	Abdominal pain	N
10	79	M	CVD	No	Cardiac failure	N
11	56	M	HCV, liver cirrhosis	No	Ascites	5 N
12	61	M	DM, HT	No	Dyspnoea	3 N
13	78	F	HT	Yes	Lower limb oedema	8 N
14	41	M	No	No	Fever and mental slowdown	6 N
15	64	F	HT	Yes	Fever and caught	2 N
16	89	F	Alzheimer disease	Yes	Caught and diarrhoea	N
17	59	M	Obesity, HT	No	Shortness of breathing	2 N
18	74	M	CVD, pharynx carcinoma	No	Loss of conscious	4 N
19	63	M	DM, HT	No	Fever, caught and dyspnoea	2 N
20	62	F	HCV, COPD	No	Melena and anaemia	Not done
21	72	M	Parkinson disease and dementia	No	Fever and dysuria	> 70 N

N: Normal value; ACT: Anticoagulant therapy; APT: Antiplatelets therapy; HT: Hypertension; CVD: Cardiovascular disorders; HCV: Hepatitis C virus; DM: Diabetes mellitus; COPD: Chronic obstructive pulmonary disease; GI: Gastrointestinal.